Cargando…
A meta-summary and bioinformatic analysis identified interleukin 6 as a master regulator of COVID-19 severity biomarkers
With the rising demand for improved COVID-19 disease monitoring and prognostic markers, studies have aimed to identify biomarkers using a range of screening methods. However, the selection of biomarkers for validation from large datasets may result in potentially important biomarkers being overlooke...
Autores principales: | Ghanem, Mohannad, Brown, Sharon J., EAT Mohamed, Aysha, Fuller, Heidi R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420723/ https://www.ncbi.nlm.nih.gov/pubmed/36067713 http://dx.doi.org/10.1016/j.cyto.2022.156011 |
Ejemplares similares
-
Mastering Perl for bioinformatics
por: Tisdall, James D
Publicado: (2003) -
Interleukin-12: A master regulator
por: Bashyam, Hema
Publicado: (2007) -
The SGML/BookMaster System at CERN: Reference Summary
por: Goossens, Michel
Publicado: (1990) -
Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013) -
Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)